Articles: EBV

The laboratory of Wistar Professor Paul M. Lieberman, Ph.D., has undertaken a historic, groundbreaking project that may change the way doctors treat a variety of human cancers. Historic, because his is the first laboratory in the United States to receive a Seeding Drug Discovery Award from Wellcome Trust, a United Kingdom-based charity.

Cancer, EBV